Anticoagulants
"Anticoagulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that prevent clotting.
Descriptor ID |
D000925
|
MeSH Number(s) |
D27.505.954.502.119
|
Concept/Terms |
Anticoagulants- Anticoagulants
- Anticoagulant Agents
- Agents, Anticoagulant
- Anticoagulant Drugs
- Drugs, Anticoagulant
|
Below are MeSH descriptors whose meaning is more general than "Anticoagulants".
Below are MeSH descriptors whose meaning is more specific than "Anticoagulants".
This graph shows the total number of publications written about "Anticoagulants" by people in UAMS Profiles by year, and whether "Anticoagulants" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2025 | 1 | 0 | 1 | 2024 | 3 | 1 | 4 | 2023 | 0 | 11 | 11 | 2022 | 0 | 4 | 4 | 2021 | 2 | 2 | 4 | 2020 | 6 | 3 | 9 | 2019 | 2 | 0 | 2 | 2018 | 5 | 0 | 5 | 2017 | 5 | 3 | 8 | 2016 | 2 | 0 | 2 | 2015 | 5 | 3 | 8 | 2014 | 8 | 3 | 11 | 2013 | 4 | 2 | 6 | 2012 | 3 | 3 | 6 | 2011 | 2 | 0 | 2 | 2010 | 3 | 2 | 5 | 2009 | 1 | 1 | 2 | 2008 | 2 | 0 | 2 | 2007 | 4 | 0 | 4 | 2006 | 1 | 1 | 2 | 2005 | 0 | 2 | 2 | 2004 | 1 | 1 | 2 | 2003 | 2 | 1 | 3 | 2002 | 2 | 0 | 2 | 1998 | 0 | 1 | 1 | 1996 | 1 | 0 | 1 | 1992 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Anticoagulants" by people in Profiles over the past ten years.
-
Corbin SL, Harris L, Fuccello A, Laryea J, Schootman M, Martin BC, Mavros MN. Clinical outcomes of extended venous thromboembolism prophylaxis after oncologic colorectal surgery. J Gastrointest Surg. 2025 May; 29(5):102018.
-
Eswaran H, Wilson S, Little J, Moll S. Livedoid vasculopathy in hemoglobinopathy-associated chronic leg ulcers. Ann Hematol. 2024 Dec; 103(12):5235-5239.
-
Reinhardt SW, Gibson DN, Hsu JC, Kapadia SR, Yeh RW, Price MJ, Piccini JP, Nair DG, Christen T, Allocco DJ, Freeman JV. Anticoagulation Alone vs Anticoagulation Plus Aspirin or DAPT Following Left?Atrial?Appendage Occlusion. J Am Coll Cardiol. 2024 Sep 03; 84(10):889-900.
-
Younes AM, Hashem A, Maraey A, Khalil M, Elzanaty A, Elgendy IY. Outcomes among patients with non-ST-elevation myocardial infarction on chronic anticoagulation: Insights from the National Inpatient Sample. Catheter Cardiovasc Interv. 2024 11; 104(5):928-933.
-
Singh RR, Thandassery RB, Chawla S. Acute Venous Thromboembolism Is Common Following Acute Necrotizing Pancreatitis and Is Associated With Worse Clinical Outcomes. Pancreas. 2024 Nov-Dec 01; 53(10):e802-e807.
-
Thind T, Heye T, Henson C, Reif R, Jensen HK, Kalkwarf KJ, Bhavaraju A, Robertson R, Jenkins A. Weight-Based Dosing for Low-Molecular-Weight Heparin (Enoxaparin) Administration to Achieve Optimal VTE Prophylaxis in Trauma Patients. Am Surg. 2024 Jun; 90(6):1406-1411.
-
Alturkmani H, Uretsky B, Patel S, Albadaineh M, Alqaisi O, Alaiwah M, Cross M, Abbasi D, Rollefson W. Safety and Efficacy of Enoxaparin During Low-Risk Elective Percutaneous Coronary Intervention. Am J Cardiol. 2024 05 01; 218:63-67.
-
Coylewright M, Holmes DR, Kapadia SR, Hsu JC, Gibson DN, Freeman JV, Yeh RW, Piccini JP, Price MJ, Allocco DJ, Nair DG. DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis. JACC Cardiovasc Interv. 2023 11 27; 16(22):2708-2718.
-
Reynolds MR, Stein AB, Sun X, Hytopoulos E, Steinhubl SR, Cohen DJ. Cost-Effectiveness of AF Screening With 2-Week Patch Monitors: The mSToPS Study. Circ Cardiovasc Qual Outcomes. 2023 11; 16(11):e009751.
-
Alharbi A, Mhanna M, Alyosif M, Pena C, Jabr A, Alsughayer A, Alfatlawi H, Safi M, Aldhafeeri A, Patel N, Khuder S, Eltahawy E. Safety and Efficacy of Direct Oral Anticoagulant in Addition to Antiplatelet Therapy After Acute Coronary Syndrome: A Systemic Review and Meta-analysis of 53,869 Patients. Clin Ther. 2024 01; 46(1):e1-e6.
-
Quinn T, Cholette JM, Pinto MG, Schreiber H, Madden MA, Bennett E, Kolmar A, Poole A, Silva CT, Ehrlich L, Navarro OM, Faustino EVS. Antithrombin activity and central venous catheter-associated thrombosis in critically ill children at high risk of bleeding. J Thromb Haemost. 2024 01; 22(1):213-224.
-
Gulati S, Hsu CY, Shah S, Shah PK, Zon R, Alsamarai S, Awosika J, El-Bakouny Z, Bashir B, Beeghly A, Berg S, de-la-Rosa-Martinez D, Doroshow DB, Egan PC, Fein J, Flora DB, Friese CR, Fromowitz A, Griffiths EA, Hwang C, Jani C, Joshi M, Khan H, Klein EJ, Heater NK, Koshkin VS, Kwon DH, Labaki C, Latif T, McKay RR, Nagaraj G, Nakasone ES, Nonato T, Polimera HV, Puc M, Razavi P, Ruiz-Garcia E, Saliby RM, Shastri A, Singh SRK, Tagalakis V, Vilar-Compte D, Weissmann LB, Wilkins CR, Wise-Draper TM, Wotman MT, Yoon JJ, Mishra S, Grivas P, Shyr Y, Warner JL, Connors JM, Shah DP, Rosovsky RP. Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19. JAMA Oncol. 2023 10 01; 9(10):1390-1400.
-
Kalkwarf KJ, Yang Y, Mora S, Wolf DA, Robertson RD, Holcomb JB, Drake SA. The silent killer: Previously undetected pulmonary emboli that result in death after discharge. Injury. 2023 Nov; 54(11):111016.
-
Konsek H, Mealer C, Skidmore S, Collins M, Tchantchaleishvili V, Rajab TK. A proposed objective scale for extracorporeal membrane oxygenation circuit thrombosis. Clin Transplant. 2023 10; 37(10):e15118.
-
Balakrishna AM, Kalathil RAM, Pusapati S, Atreya A, Mehta A, Bansal M, Aggarwal V, Basir MB, Kochar A, Truesdell AG, Vallabhajosyula S. Comparative Outcomes of Catheter-Directed Thrombolysis Plus Systemic Anticoagulation Versus Systemic Anticoagulation Alone in the Management of Intermediate-Risk Pulmonary Embolism in a Systematic Review and Meta-Analysis. Am J Cardiol. 2023 10 15; 205:249-258.
-
Mavros MN, Johnson LA, Schootman M, Orcutt ST, Peng C, Martin BC. Adherence to Extended Venous Thromboembolism Prophylaxis and Outcomes After Complex Gastrointestinal Oncologic Surgery. Ann Surg Oncol. 2023 Sep; 30(9):5522-5531.
-
Kar S, Doshi SK, Alkhouli M, Camm AJ, Coylewright M, Gibson MC, Granger CB, Gurol ME, Huber K, Mansour M, Nair DG, Natale A, Pocock SJ, Reddy VR, Saliba W, Christen T, Allocco DJ, Ellenbogen KA, Leon MB. Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation. Am Heart J. 2023 10; 264:123-132.
-
Desai R, Mondal A, Prasad A, Vyas A, Jain A, Rupareliya C, Shah M, Paul T, Kumar G, Sachdeva R. Concurrent Cardio-Cerebral Infarctions in COVID-19: A Systematic Review of Published Case Reports/Series. Curr Probl Cardiol. 2023 Oct; 48(10):101814.
-
Bhatia K, Ladd LM, Carr KH, Di Napoli M, Saver JL, McCullough LD, Hosseini Farahabadi M, Alsbrook DL, Hinduja A, Ortiz Garcia JG, Sabbagh SY, Jafarli A, Divani AA. Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines. Curr Neurol Neurosci Rep. 2023 05; 23(5):235-262.
-
Lancaster I, Sethi V, Patel D, Tamboli C, Pacer E, Steinhoff J, Mizrahi M, Willinger A. Antithrombotics and Gastrointestinal Prophylaxis: A Systematic Review. Cardiol Rev. 2024 Nov-Dec 01; 32(6):528-537.
-
Sherard C, Bisbee C, Konsek H, Kang L, Turek JW, Rajab TK. Partial Heart Transplantation in Adult Cardiac Surgery. Innovations (Phila). 2023 Mar-Apr; 18(2):126-131.
-
Inanc IH, Cilingiroglu M, Iliescu C, NInios V, Matar F, Ates I, Toutouzas K, Hermiller J, Marmagkiolis K. Comparison of American and European Guidelines for the Management of Patients With Valvular Heart Disease. Cardiovasc Revasc Med. 2023 Feb; 47:76-85.
-
Bennett E, Delgado-Corcoran C, Pannucci CJ, Wilcox R, Heyrend C, Faustino EV. Outcomes of Prophylactic Enoxaparin Against Venous Thromboembolism in Hospitalized Children. Hosp Pediatr. 2022 06 01; 12(6):617-625.
-
Mhanna M, Beran A, Al-Abdouh A, Jabri A, Al-Aaraj A, Sajdeya O, Abuhelwa Z, Khokher W, Bhuta S, Burmeister CJ, Eltahawy EA. Single Versus Dual Antiplatelet Therapy following Left Atrial Appendage Occlusion in Patients With High Bleeding Risk. Curr Probl Cardiol. 2022 Sep; 47(9):101269.
-
Steensig K, Pareek M, Krarup AL, Sogaard P, Maeng M, Tayal B, Lee CJ, Torp-Pedersen C, Lip GY, Holland-Fischer P, Kragholm KH. Thromboembolism and bleeding in patients with atrial fibrillation and liver disease - A nationwide register-based cohort study: Thromboembolism and bleeding in liver disease. Clin Res Hepatol Gastroenterol. 2022 10; 46(8):101952.
-
Hermann RP, Rockey DC, Suzuki A, Merz M, Tillmann HL. A novel phenotype-based drug-induced liver injury causality assessment tool (DILI-CAT) allows for signal confirmation in early drug development. Aliment Pharmacol Ther. 2022 04; 55(8):1028-1037.
-
Vallurupalli S, Sharma T, Al'Aref S, Devabhaktuni SR, Dhar G. Left Atrial Appendage Closure: An Alternative to Anticoagulation for Stroke Prevention in Patients with Kidney Disease. Kidney360. 2022 02 24; 3(2):396-402.
-
Curtis HJ, MacKenna B, Walker AJ, Croker R, Mehrkar A, Morton C, Bacon S, Hickman G, Inglesby P, Bates C, Evans D, Ward T, Cockburn J, Davy S, Bhaskaran K, Schultze A, Rentsch CT, Williamson E, Hulme W, Tomlinson L, Mathur R, Drysdale H, Eggo RM, Wong AY, Forbes H, Parry J, Hester F, Harper S, Douglas I, Smeeth L, Goldacre B. OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic. Open Heart. 2021 11; 8(2).
-
Briggler R, Matherne E, Johnson C, Boehmer K. Recurrent Thrombi in an Obese Patient With History of Bariatric Surgery Despite Anti-Xa Therapy. J Pharm Pract. 2022 Oct; 35(5):811-816.
-
Rech MA, Masic D, Hammond DA. Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding. West J Emerg Med. 2021 Feb 26; 22(2):163-169.
-
Kelley KM, Galvagno SM, Wallis M, Mazzeffi MA, Deatrick K, Betzold R, Scalea T, Menaker J. Tracheostomy in Patients on Venovenous Extracorporeal Membrane Oxygenation: Is It Safe? Am Surg. 2021 Aug; 87(8):1292-1298.
-
Mavros MN, Coburn NG, Davis LE, Zuk V, Hallet J. Risk of venous thromboembolism in patients with elevated INR undergoing hepatectomy: an analysis of the American college of surgeons national surgical quality improvement program registry. HPB (Oxford). 2021 07; 23(7):1008-1015.
-
Rettenmaier LA, Garg A, Limaye K, Leira EC, Adams HP, Shaban A. Management of Ischemic Stroke Following Left Ventricular Assist Device. J Stroke Cerebrovasc Dis. 2020 Dec; 29(12):105384.
-
Omecene NE, Kishk OA, Lardieri AB, Walker LK, Bhutta AT. Comparison of Antithrombin III Products in Pediatric Patients Receiving Extracorporeal Membrane Oxygenation. ASAIO J. 2020 Sep/Oct; 66(9):1042-1047.
-
Yaghi S, Mistry E, Liberman AL, Giles J, Asad SD, Liu A, Nagy M, Kaushal A, Azher I, Mac Grory B, Fakhri H, Brown Espaillat K, Pasupuleti H, Martin H, Tan J, Veerasamy M, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Scher E, Trivedi T, Lord A, Furie K, Keyrouz S, Nouh A, Leon Guerrero CR, de Havenon A, Khan M, Henninger N. Anticoagulation Type and Early Recurrence in Cardioembolic Stroke: The IAC Study. Stroke. 2020 09; 51(9):2724-2732.
-
Yaghi S, Trivedi T, Henninger N, Giles J, Liu A, Nagy M, Kaushal A, Azher I, Mac Grory B, Fakhri H, Brown Espaillat K, Asad SD, Pasupuleti H, Martin H, Tan J, Veerasamy M, Liberman AL, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Scher E, Leon Guerrero CR, Khan M, Nouh A, Mistry E, Keyrouz S, Furie K. Anticoagulation Timing in Cardioembolic Stroke and Recurrent Event Risk. Ann Neurol. 2020 10; 88(4):807-816.
-
Corona LE, Singhal U, Hafez K, Herrel LA, Kaffenberger SD, Montgomery JS, Morgan TM, Weizer AZ, Qin Y, Ambani SN. Rethinking the one-size-fits-most approach to venous thromboembolism prophylaxis after radical cystectomy. Urol Oncol. 2020 10; 38(10):797.e1-797.e6.
-
Yaghi S, Liberman AL, Henninger N, Grory BM, Nouh A, Scher E, Giles J, Liu A, Nagy M, Kaushal A, Azher I, Fakhri H, Espaillat KB, Asad SD, Pasupuleti H, Martin H, Tan J, Veerasamy M, Esenwa C, Cheng N, Moncrieffe K, Moeini-Naghani I, Siddu M, Trivedi T, Ishida K, Frontera J, Lord A, Furie K, Keyrouz S, de Havenon A, Mistry E, Leon Guerrero CR, Khan M. Factors associated with therapeutic anticoagulation status in patients with ischemic stroke and atrial fibrillation. J Stroke Cerebrovasc Dis. 2020 Jul; 29(7):104888.
-
Randhawa MS, Vishwanath R, Rai MP, Wang L, Randhawa AK, Abela G, Dhar G. Association Between Use of Warfarin for Atrial Fibrillation and Outcomes Among Patients With End-Stage Renal Disease: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020 04 01; 3(4):e202175.
-
Citla Sridhar D, Abou-Ismail MY, Ahuja SP. Central venous catheter-related thrombosis in children and adults. Thromb Res. 2020 03; 187:103-112.
-
Greenberg JW, Goff ZD, Mooser AC, Wittgen CM, Smeds MR. Acute Limb Ischemia Secondary to Patent Foramen Ovale-Mediated Paradoxical Embolism: A Case Report and Systematic Review of the Literature. Ann Vasc Surg. 2020 Jul; 66:668.e5-668.e10.
-
Kamran S, Akhtar N, George P, Singh R, Imam Y, Salam A, Babu B, Burke P, Own A, Vattoth S, Perkins J, Parray A, Qadri S, Hamid T. Embolic Pattern of Stroke Associated with Cardiac Wall Motion Abnormalities; Narrowing the Embolic Stroke of Undetermined Source Category. J Stroke Cerebrovasc Dis. 2020 Feb; 29(2):104509.
-
Kattoor AJ, Pothineni NV, Goel A, Syed M, Syed S, Paydak H, Mehta JL. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis. J Cardiovasc Pharmacol Ther. 2019 09; 24(5):428-434.
-
Patel DM, Patel MV, Patel AD, Kaklotar JC, Patel GR, Patel MM. Non-uremic Calciphylaxis: A Rare and Late Adverse Reaction of Warfarin. Curr Drug Saf. 2019; 14(3):246-248.
-
Pouncey DL, Hartman JH, Moore PC, Dillinger DJ, Dickerson KW, Sappington DR, Smith ES, Boysen G, Miller GP. Novel isomeric metabolite profiles correlate with warfarin metabolism phenotype during maintenance dosing in a pilot study of 29 patients. Blood Coagul Fibrinolysis. 2018 Nov; 29(7):602-612.
-
Taggart NW, Gordon BM, Morgan GJ, Goldstein BH. Variation in Anticoagulation Practices in the Congenital Cardiac Catheterization Lab: Results of a Multinational PICES Survey. Pediatr Cardiol. 2019 Jan; 40(1):53-60.
-
Ghannam M, Chugh A, Dillon P, Alyesh D, Kossidas K, Sharma S, Coatney J, Atreya A, Yokokawa M, Saeed M, Cunnane R, Ghanbari H, Latchamsetty R, Crawford T, Jongnarangsin K, Bogun F, Pelosi F, Morady F, Oral H. Protamine to expedite vascular hemostasis after catheter ablation of atrial fibrillation: A randomized controlled trial. Heart Rhythm. 2018 11; 15(11):1642-1647.
-
Corwin HL, Shander A. Conjecture and Fact: Prothrombin Complex Concentrates for Bleeding With Vitamin K Antagonists. Crit Care Med. 2018 06; 46(6):1020-1022.
-
Jain N, Reilly RF. Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease. Clin J Am Soc Nephrol. 2019 02 07; 14(2):278-287.
-
Mack JM, Richter GT, Crary SE. Effectiveness and Safety of Treatment with Direct Oral Anticoagulant Rivaroxaban in Patients with Slow-Flow Vascular Malformations: A Case Series. Lymphat Res Biol. 2018 06; 16(3):278-281.
-
Smer A, Salih M, Mahfood Haddad T, Guddeti R, Saadi A, Saurav A, Belbase R, Ayan M, Traina M, Alla V, Del Core M. Meta-analysis of Randomized Controlled Trials on Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Prevention of Cryptogenic Stroke. Am J Cardiol. 2018 06 01; 121(11):1393-1399.
-
Przybyla B, Pinom?ki A, Pet?j? J, Joutsi-Korhonen L, Strandberg K, Hillarp A, ?hlin AK, Ruutu T, Volin L, Lassila R. Coordinated responses of natural anticoagulants to allogeneic stem cell transplantation and acute GVHD - A longitudinal study. PLoS One. 2017; 12(12):e0190007.
-
Battle B, Sexton KW, Fitzgerald RT. Understanding the Value of Repeat Head?CT in Elderly Trauma Patients on Anticoagulant?or?Antiplatelet Therapy. J Am Coll Radiol. 2018 02; 15(2):319-321.
-
Shunkwiler SM, Pham HP, Wool G, Ipe TS, Fang DC, Biller E, Treml A, Weiss J, Baron BW, Berg M. The management of anticoagulation in patients undergoing therapeutic plasma exchange: A concise review. J Clin Apher. 2018 Jun; 33(3):371-379.
-
Kaatz S, Mahan CE, Nakhle A, Gunasekaran K, Ali M, Lavender R, Paje DG. Management of Elective Surgery and Emergent Bleeding with Direct Oral Anticoagulants. Curr Cardiol Rep. 2017 10 24; 19(12):124.
-
Pritchard ER, Murillo JR, Putney D, Hobaugh EC. Single-center, retrospective evaluation of safety and efficacy of direct oral anticoagulants versus low-molecular-weight heparin and vitamin K antagonist in patients with cancer. J Oncol Pharm Pract. 2019 Jan; 25(1):52-59.
-
Connor MJ, Karakala N. Continuous Renal Replacement Therapy: Reviewing Current Best Practice to Provide High-Quality Extracorporeal Therapy to Critically Ill Patients. Adv Chronic Kidney Dis. 2017 07; 24(4):213-218.
-
Barnette DA, Johnson BP, Pouncey DL, Nshimiyimana R, Desrochers LP, Goodwin TE, Miller GP. Stereospecific Metabolism of R- and S-Warfarin by Human Hepatic Cytosolic Reductases. Drug Metab Dispos. 2017 09; 45(9):1000-1007.
-
Habash F, Vallurupalli S. Challenges in management of left ventricular thrombus. Ther Adv Cardiovasc Dis. 2017 Aug; 11(8):203-213.
-
Saad M, Nairooz R, Rashed A, Abdelaziz HK, Mentias A, Abbott JD. Bivalirudin versus heparin in women undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials. Cardiovasc Revasc Med. 2017 Sep; 18(6):418-424.
-
Iyengar A, Hung ML, Asanad K, Kwon OJ, Jackson NJ, Reemtsen BL, Federman MD, Biniwale RM. Association Between Hematologic and Inflammatory Markers and 31 Thrombotic and Hemorrhagic Events in Berlin Heart Excor Patients. Pediatr Cardiol. 2017 Apr; 38(4):770-777.
-
El-Menyar A, Asim M, Jabbour G, Al-Thani H. Clinical implications of the anatomical variation of deep venous thrombosis. Phlebology. 2018 Mar; 33(2):97-106.
-
Shah A, Shewale A, Hayes CJ, Martin BC. Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients. Stroke. 2016 06; 47(6):1555-61.
-
Sen P, Kundu A, Sardar P, Chatterjee S, Nairooz R, Amin H, Aronow WS. Outcomes After Cardioversion in Atrial Fibrillation Patients Treated with Non-Vitamin K Antagonist Oral Anticoagulants (NOACs): Insights from a Meta-Analysis. Am J Cardiovasc Drugs. 2016 Feb; 16(1):33-41.
-
Niebler RA, Woods KJ, Murkowski K, Ghanayem NS, Hoffman G, Mitchell ME, Punzalan RC, Scott JP, Simpson P, Tweddell JS. A Pilot Study of Antithrombin Replacement Prior to Cardiopulmonary Bypass in Neonates. Artif Organs. 2016 Jan; 40(1):80-5.
-
Ayoub K, Nairooz R. Duration of Triple Therapy: A Clinical Question Remains Unanswered. Clin Cardiol. 2015 Dec; 38(12):777.
-
Joy PS, Kumar G, Guddati AK, Bhama JK, Cadaret LM. Risk Factors and Outcomes of Gastrointestinal Bleeding in Left Ventricular Assist Device Recipients. Am J Cardiol. 2016 Jan 15; 117(2):240-4.
-
Kraleti S. Budd-Chiari Syndrome in a patient with Multiple Hypercoagulopathies. J Ark Med Soc. 2015 Oct; 112(6):90-1.
-
Nairooz R, Ayoub K, Sardar P, Payne J, Almomani A, Pothineni NV, Shailesh F, Aronow WS, Mukherjee D. Uninterrupted New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Ablation of Atrial Fibrillation: A Meta-analysis. Can J Cardiol. 2016 06; 32(6):814-23.
-
Limaye K, Abla AA. We Will Use Antiplatelets As Our First Choice for Prevention of Stroke Recurrence in Cervical Arterial Dissection After Reading CADISS--Will You? World Neurosurg. 2015 Nov; 84(5):1182-4.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|